Erasca to Present at Upcoming Investor Conferences in June
Erasca (NASDAQ: ERAS), a clinical-stage precision oncology company focused on RAS/MAPK pathway-driven cancer therapies, has announced its participation in two major investor conferences in June 2025:
1. Jefferies Global Healthcare Conference (June 3-5) in New York, featuring a fireside chat on June 4 at 5:30 PM ET
2. Goldman Sachs 46th Annual Global Healthcare Conference (June 9-11) in Miami Beach, with a fireside chat scheduled for June 10 at 2:40 PM ET
Management will participate in one-on-one investor meetings at both conferences. Live audio webcasts will be available at Erasca.com/events, with replays accessible for 30 days after each event.
Erasca (NASDAQ: ERAS), un'azienda in fase clinica specializzata in oncologia di precisione focalizzata sulle terapie per il cancro guidate dalla via RAS/MAPK, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025:
1. Jefferies Global Healthcare Conference (3-5 giugno) a New York, con un incontro informale previsto per il 4 giugno alle 17:30 ET
2. Goldman Sachs 46th Annual Global Healthcare Conference (9-11 giugno) a Miami Beach, con un incontro informale programmato per il 10 giugno alle 14:40 ET
Il management parteciperà a incontri individuali con investitori in entrambe le conferenze. Saranno disponibili webcast audio in diretta su Erasca.com/events, con repliche accessibili per 30 giorni dopo ogni evento.
Erasca (NASDAQ: ERAS), una empresa clínica de oncología de precisión centrada en terapias contra el cáncer impulsadas por la vía RAS/MAPK, ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025:
1. Jefferies Global Healthcare Conference (3-5 de junio) en Nueva York, con una charla informal el 4 de junio a las 5:30 PM ET
2. Goldman Sachs 46th Annual Global Healthcare Conference (9-11 de junio) en Miami Beach, con una charla informal programada para el 10 de junio a las 2:40 PM ET
La dirección participará en reuniones individuales con inversores en ambas conferencias. Habrá retransmisiones de audio en vivo disponibles en Erasca.com/events, con repeticiones accesibles durante 30 días después de cada evento.
Erasca (NASDAQ: ERAS)는 RAS/MAPK 경로 기반 암 치료에 중점을 둔 임상 단계 정밀 종양학 회사로, 2025년 6월 두 개의 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다:
1. Jefferies Global Healthcare Conference (6월 3-5일) 뉴욕에서 개최되며, 6월 4일 오후 5시 30분(동부시간)에 파이어사이드 채팅이 진행됩니다.
2. Goldman Sachs 제46회 연례 글로벌 헬스케어 컨퍼런스 (6월 9-11일) 마이애미 비치에서 개최되며, 6월 10일 오후 2시 40분(동부시간)에 파이어사이드 채팅이 예정되어 있습니다.
경영진은 두 컨퍼런스에서 1:1 투자자 미팅에 참여할 예정입니다. 라이브 오디오 웹캐스트는 Erasca.com/events에서 제공되며, 각 이벤트 후 30일간 다시보기 가능합니다.
Erasca (NASDAQ : ERAS), une société en phase clinique spécialisée en oncologie de précision axée sur les thérapies du cancer liées à la voie RAS/MAPK, a annoncé sa participation à deux grandes conférences pour investisseurs en juin 2025 :
1. Jefferies Global Healthcare Conference (3-5 juin) à New York, avec une discussion informelle prévue le 4 juin à 17h30 ET
2. Goldman Sachs 46e conférence annuelle mondiale sur la santé (9-11 juin) à Miami Beach, avec une discussion informelle programmée le 10 juin à 14h40 ET
La direction participera à des réunions individuelles avec les investisseurs lors des deux conférences. Des webcasts audio en direct seront disponibles sur Erasca.com/events, avec des rediffusions accessibles pendant 30 jours après chaque événement.
Erasca (NASDAQ: ERAS), ein klinisch fortgeschrittenes Präzisions-Onkologie-Unternehmen mit Fokus auf Krebsbehandlungen, die durch den RAS/MAPK-Signalweg gesteuert werden, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Juni 2025 angekündigt:
1. Jefferies Global Healthcare Conference (3.-5. Juni) in New York, mit einem Fireside-Chat am 4. Juni um 17:30 Uhr ET
2. Goldman Sachs 46. jährliche globale Gesundheitskonferenz (9.-11. Juni) in Miami Beach, mit einem Fireside-Chat am 10. Juni um 14:40 Uhr ET
Das Management wird bei beiden Konferenzen Einzelgespräche mit Investoren führen. Live-Audio-Webcasts sind unter Erasca.com/events verfügbar, mit Wiederholungen, die 30 Tage nach jeder Veranstaltung abrufbar sind.
- None.
- None.
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences in June 2025 and will also participate in one-on-one investor meetings at each of these conferences.
Jefferies Global Healthcare Conference (June 3-5, 2025)
Location: New York, NY
Format: Fireside Chat
Date and Time: Wednesday, June 4, 5:30 pm Eastern Time
Goldman Sachs 46th Annual Global Healthcare Conference (June 9-11, 2025)
Location: Miami Beach, FL
Format: Fireside Chat
Date and Time: Tuesday, June 10, 2:40 pm Eastern Time
A live audio webcast of the events will be available online at Erasca.com/events. An archived replay of the events will be available for 30 days following the webcast at Erasca.com/events.
About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of patients with cancer. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.
Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com
Source: Erasca, Inc.
FAQ
When and where will Erasca (ERAS) present at the Jefferies Healthcare Conference in June 2025?
When is Erasca's (ERAS) presentation at the Goldman Sachs Healthcare Conference 2025?
How can investors access Erasca's (ERAS) conference presentations in June 2025?
What type of company is Erasca (ERAS)?
